Former Football Star's Bold Turmeric Claims Under the Microscope
Hal Robson-Kanu, the ex-Premier League forward, asserts that his turmeric-based products can combat inflammation, chronic pain, and various ailments. He goes further, claiming they could save the National Health Service a staggering £23 billion each year by completely eradicating the need for related care. While the 36-year-old entrepreneur is undoubtedly a confident promoter, the validity of his assertions warrants closer examination.
From Pitch to Business: The Rise of The Turmeric Co
Robson-Kanu founded The Turmeric Co in 2018, drawing inspiration from his own athletic career. After suffering a severe cruciate knee ligament injury as a teenager at Reading, which he describes as his leg being snapped in half, he turned to natural remedies during recovery. Alongside his father, Rechi, he researched herbs like turmeric, ginger, pomegranate, and pineapple, blending them into what he calls his secret weapon for faster muscle recovery and immune support.
The company produces bottled shots containing raw turmeric root, marketed to reduce inflammation and enhance wellness. Despite his bold claims, the products have gained significant traction, available in major retailers such as Boots, Sainsbury's, Tesco, and David Lloyd Clubs. Partnerships with Premier League clubs like Liverpool, Everton, and Brentford further underscore their popularity.
Commercial Success and Regulatory Challenges
The Turmeric Co has achieved notable commercial milestones. In 2018, Robson-Kanu sold a minority stake for a seven-figure sum to investors, including founders of the Rubicon drinks brand and comedian Joel Dommett. More recently, in 2023, his company Innate-Essence sold a 50.01% majority stake to AG Barr, makers of Irn Bru, for £15 million.
However, the business has faced regulatory scrutiny. In 2021, the Advertising Standards Authority (ASA) ruled that one of their social media promotions breached UK advertising codes by implying that food could prevent, treat, or cure diseases. The company had advertised shots with promises like Bid farewell to stubborn aches and pains. Robson-Kanu and his team acknowledged the issue and committed to avoiding such claims in future advertisements.
Grandiose Statements and the £23 Billion NHS Promise
Despite advertising restrictions, Robson-Kanu continues to make ambitious declarations on platforms like podcasts. He recently told the Performance People podcast that his vision includes having Turmeric Co products prescribed by the NHS to democratise health. He argues that shifting from a treatment-based to a preventative system could eliminate £23 billion in annual NHS costs tied to inflammation and chronic pain.
The origin of this £23 billion figure remains unclear, and its scale is substantial. With the Department of Health and Social Care allocating approximately £187 billion to NHS England for 2024-25, Robson-Kanu's claim suggests his products could save about 12.3% of the annual budget—a monumental assertion for a turmeric-based startup.
Health Benefits and Potential Risks of Turmeric
Turmeric, a flowering plant native to Asia, contains curcumin, an active compound with anti-inflammatory and antioxidant properties. Studies support its benefits for heart health and overall wellness, aligning with Robson-Kanu's promotional messages. However, his claim that turmeric has no side effects is not entirely accurate.
In high doses, curcumin can lead to adverse effects, including:
- Increased bleeding risk due to its natural blood-thinning properties
- Worsening of gallstones or contribution to kidney stones
- Digestive issues such as nausea, diarrhoea, and stomach irritation
- Potential interactions with medications like Aspirin or Warfarin
While moderate consumption is generally safe, individuals should consult healthcare providers, especially if combining turmeric with existing treatments.
Conclusion: A Promising Venture with Exaggerated Claims?
Hal Robson-Kanu's journey from football star to wellness entrepreneur is compelling, and The Turmeric Co's market success indicates a genuine consumer interest. His personal story of overcoming injury adds credibility, and the health benefits of turmeric are well-documented. Yet, the £23 billion NHS savings promise appears inflated, and past advertising missteps highlight the need for cautious marketing. Ultimately, while turmeric shots may offer health advantages, expecting them to revolutionise healthcare funding seems overly optimistic.
